Valacyclovir Hydrochloride (Valtrex) 500 mg and 1 g tablets: 8 generic players got final approval from USFDA

Following 8 generic players have obtained final approval to market generic version of Valacyclovir (Valtrex) 500 mg and 1 g tablets in US market:

1. Dr. Reddy's Laboratories

2. Mylan Pharmaceuticals Inc: http://investor.mylan.com/releasedetail.cfm?ReleaseID=473489
3. Matrix Laboratories Ltd.

4. Roxane Laboratories, Inc.

5. Sandoz Inc.,

6. Teva Pharmaceuticals USA: http://www.tevapharm.com/pr/2010/pr_936.asp

7. Watson Laboratories, Inc: http://ir.watson.com/phoenix.zhtml?c=65778&p=irol-newsArticle&ID=1430538

8. Aurobindo Pharma USA, Inc: http://www.aurobindo.com/

The above generic players have obtained final approval from USFDA after the expiry of Ranbaxy's 180 days FTF exclusivity on May 25, 2010.

Please refer to my earlier post on Ranbaxy’s FTF exclusivity http://ippharmdoc.blogspot.com/search?q=valacyclovir